Economic Evaluation of Therapeutic Drug Monitoring and Precision Dosing in Pediatrics: A Short Communication
The lack of standardized methodologies and economic endpoints, along with potential underreporting of negative findings, restricts the generalizability of conclusions. Nevertheless, current evidence supports TDM-MIPD as a potentially cost-effective approach in pediatric pharmacotherapy.
Authors
- Guillermo Federico Taboada (ORCID: https://orcid.org/0000-0002-5644-7771)
- Paulo Cáceres Guidó (ORCID: https://orcid.org/0000-0002-9747-4960)
- Víctor E. Lechuga-Noa
Institutions
- Universidad Científica del Sur (PE)
- Garrahan Hospital (AR)
- EsSALUD (PE)
Publication Details
- Journal
- Therapeutic Drug Monitoring
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1097/ftd.0000000000001424
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00